Cocrystal Pharma Inc. (COCP)
COCP trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.08
+1.89% on the day
Market cap
$20.8M
Nano cap
Revenue
No annual revenue filed since the period ending 2020-12-31
Net income
No annual revenue filed since the period ending 2020-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | COCP on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001412486 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2020-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-04-23 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-09-09 |
| Latest proxy | DEFA14A | 2026-05-27 |
Source: SEC EDGAR submissions feed, 672 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| UPC | Universe Pharmaceuticals Inc. | $4.27 | +3.39% | $21.5M |
| OPTH | Optimi Health Corp. Common Shares | $3.50 | -3.58% | $20.0M |
| AYTU | Aytu BioPharma Inc. | $1.99 | +1.01% | $21.6M |
| QNRX | Quoin Pharmaceuticals Ltd. | $4.15 | -4.82% | $19.9M |
| TXMD | TherapeuticsMD Inc. | $1.96 | -2.97% | $22.7M |
| NEUP | Neuphoria Therapeutics Inc. | $3.39 | +2.11% | $18.3M |
| KYNB | Kyntra Bio Inc. | $5.87 | -4.08% | $23.8M |
| AKTX | Akari Therapeutics plc ADS | $7.90 | -7.49% | $18.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier